FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene

被引:362
|
作者
Zuo, Tao
Wang, Lizhong
Morrison, Carl
Chang, Xing
Zhang, Huiming
Li, Weiquan
Liu, Yan
Wang, Yin
Liu, Xingluo
Chan, Michael W. Y.
Liu, Jin-Qing
Love, Richard
Liu, Chang-gong
Godfrey, Virginia
Shen, Rulong
Huang, Tim H. -M.
Yang, Tianyu
Park, Bae Keun
Wang, Cun-Yu
Zheng, Pan [1 ]
Liu, Yang
机构
[1] Univ Michigan, Ctr Comprehens Canc, Dept Surg, Sect Gen Surg,Div Immunotherapy, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Program Mol Mech Dis, Ann Arbor, MI 48109 USA
[3] Ohio State Univ, Med Ctr, Dept Virol Immunol & Med Genet, Program Mol Cellular & Dev Biol, Columbus, OH 43210 USA
[4] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA
[5] Ohio State Univ, Med Ctr, Dept Internal Med, Columbus, OH 43210 USA
[6] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[7] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA
[8] Univ Michigan, Dept Biol & Mat Sci, Lab Mol Signaling & Apoptosis, Sch Dent, Ann Arbor, MI 48109 USA
关键词
D O I
10.1016/j.cell.2007.04.034
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The X-linked Foxp3 is a member of the forkhead/winged helix transcription factor family. Germline mutations cause lethal autoimmune diseases in males. Serendipitously, we observed that female mice heterozygous for the "scurfin'' mutation of the Foxp3 gene (Foxp3(sf/+)) developed cancer at a high rate. The majority of the cancers were mammary carcinomas in which the wild-type Foxp3 allele was inactivated and HER-2/ErbB2 was overexpressed. Foxp3 bound and repressed the HER-2/ErbB2 promoter. Deletion, functionally significant somatic mutations, and downregulation of the FOXP3 gene were commonly found in human breast cancer samples and correlated significantly with HER-2/ErbB2 overexpression, regardless of the status of HER-2 amplification. Our data demonstrate that FOXP3 is an X-linked breast cancer suppressor gene and an important regulator of the HER-2/ErbB2 oncogene.
引用
收藏
页码:1275 / 1286
页数:12
相关论文
共 50 条
  • [31] HER-2/neu oncogene amplification in breast cancer.
    Depowski, PL
    Brien, TP
    Sheehan, CE
    Muraca, PJ
    Stylos, S
    Johnson, RL
    Ross, JS
    LABORATORY INVESTIGATION, 1998, 78 (01) : 18A - 18A
  • [32] Update on HER-2 as a target for cancer therapy: The ERBB2 promoter and its exploitation for cancer treatment
    Helen C Hurst
    Breast Cancer Research, 3
  • [33] Update on HER-2 as a target for cancer therapy -: The ERBB2 promoter and its exploitation for cancer treatment
    Hurst, HC
    BREAST CANCER RESEARCH, 2001, 3 (06) : 395 - 398
  • [34] IMMUNOHISTOCHEMICAL DEMONSTRATION OF THE C-ERBB-2 HER-2 ONCOGENE IN HUMAN-BREAST CARCINOMAS
    GUSTERSON, BA
    GULLICK, WJ
    VENTER, DJ
    HARRISON, S
    ELLIOTT, C
    BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (01) : 121 - 121
  • [35] Simultaneous amplification of Topoisomerase II alpha (TOP2A) and HER-2 (ERBB2) is rare in select patients with breast cancer
    Primeaux, T. M.
    Martin, S.
    Nordberg, M. L.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (05): : 687 - 687
  • [36] Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer
    Savinainen, KJ
    Saramäki, OR
    Linja, MJ
    Bratt, O
    Tammela, TLJ
    Isola, JJ
    Visakorpi, T
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (01): : 339 - 345
  • [37] Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
    Harari, D
    Yarden, Y
    ONCOGENE, 2000, 19 (53) : 6102 - 6114
  • [38] A modified approach for I-FISH evaluation of ERBB2 (HER-2) gene copy numbers in breast carcinomas: comparison with HER-2/CEP17 ratio system
    Marcela Mrhalova
    Roman Kodet
    Journal of Cancer Research and Clinical Oncology, 2007, 133 : 321 - 329
  • [39] Future options in the treatment of ErbB2 (HER2)-positive breast cancer
    Fumoleau, Pierre
    EJC SUPPLEMENTS, 2008, 6 (05): : 25 - 31
  • [40] Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
    Daniel Harari
    Yosef Yarden
    Oncogene, 2000, 19 : 6102 - 6114